To that end, BUB1 was one of the top nominated of the 52 kinases as it showed significantly elevated expression in triple-negative and basal-like breast cancers and limited expression in normal tissues (Fig. 1A-B, data based on expression in over 1000 patient tumors from TCGA). Here, BUB1 is linked to breast carcinoma.